fbpx

Safilo Strengthens its Presence in Chile

Padua/Santiago de Chile – Safilo Group announces an exclusive distribution partnership agreement for Chile with Valente Eyewear & Trade, leading local operator of long standing tradition, proven capability and industry trust.

Product centric, brand driven and design inspired, Safilo dates its craftsmanship tradition back to 1878, and today offers more than 30 leading brands across all consumer segments – exciting and fast-growing Mass/Cool with Polaroid and Havaianas; Lifestyle Carrera, Tommy Hilfiger, Kate Spade, Marc Jacobs; Sports and Outdoor Smith; Premium Boss and Max Mara; Fashion/Luxury Dior, Jimmy Choo, Fendi, Givenchy; and highest-end Atelier Elie Saab, Oxydo; and Specialist Safilo.

“We are committed to broaden the market offer in Chile with our globally leading eyewear brands of trend setting design and technical product sophistication. We see an opportunity in Chile for international eyewear brand building and further development of eyewear retailing across all our segments,” says Luisa Delgado, CEO of Safilo. “We are delighted to welcome Valente Eyewear & Trade to our global Partner Network. With their proven 30-year industry track record and capability, they are uniquely positioned to offer for us to local retailers the best industry standards of customer service, in store communication and merchandising, and to lead local consumer engagement with specific focus on our own core brands.”

“We are proud to have the opportunity to partner with Safilo to build their brands in Chile. We will focus on targeted distribution, highest levels of local service, and local consumer communication. Safilo is recognized worldwide for the industry leading design and quality of its eyewear, and high distribution standards. It is an honour for us to work with Safilo for the long-  term development of that business model in our country,” say Álvaro and Maria Valente, owners of Valente Eyewear & Trading.

The Chilean market is a further addition to Safilo’s Latin America Division (LA), established in late 2013 in the context of its 2020 Strategic Plan. LA encompasses subsidiaries in Brazil and Mexico, a Miami based regional office with a global Showroom, and partner markets across key LA countries, namely Argentina since last year, and now Chile. The region’s development has been spearheaded by strong Brand PR & communication supporting a commercial strategy of qualitative distribution, in store communication and merchandising, and open trade terms based on performance, that have resonated in building partnerships of trust with retail customers across Latin America.

Click HERE for full press release.

 

Featured Posts

Essilor Varilux physop extensee logo

Essilor Announces Latest Progressive Lens Innovation: Varilux® Physio® extensee Lens

Discover Varilux Physio extensee™, Essilor’s latest innovation in progressive lenses—sharp vision, better contrast, and pupil-adaptive comfort in all light.

Learn More
CooperVision

MiSight® Spectacle Lenses Powered by Diffusion Optics Technology™ Launches in Canada to Slow Myopia Progression

Breakthrough Approach First to Use Contrast Management, Supported by Extensive Clinical Studies; Proven Highly Effective in Children as Young as Six Years Old

Read more
Optik Voila May-June 2025 Mood Le PArc Marcellis

LE PARC – Timeless Lines, a Bold Perspective

From the Spring/Summer 2025 collection and “Dots” campaign, Marcelis is a sophisticated combination of acetate textures and timeless lines.

Read more
Safilo Group Victoria Beckham logos July 2025

Safilo, Victoria Beckham Announce Ten-Year Global Licensing Agreement for Eyewear Collections

Safilo and Victoria Beckham announce a global ten-year eyewear licensing agreement through 2035, with a new luxury collection debuting Spring-Summer 2026.

Read more
Fighting Blindness Canada research

AIPL1 Gene Therapy Restores vision in small clinical trial

Four children with Leber congenital amaurosis 4 (LCA4) have experienced meaningful improvements in their vision after receiving a gene therapy treatment.

Read more
Essilor Varilux physop extensee logo

Essilor Announces Latest Progressive Lens Innovation: Varilux® Physio® extensee Lens

Discover Varilux Physio extensee™, Essilor’s latest innovation in progressive lenses—sharp vision, better contrast, and pupil-adaptive comfort in all light.

Learn More
CooperVision

MiSight® Spectacle Lenses Powered by Diffusion Optics Technology™ Launches in Canada to Slow Myopia Progression

Breakthrough Approach First to Use Contrast Management, Supported by Extensive Clinical Studies; Proven Highly Effective in Children as Young as Six Years Old

Read More
Optik Voila May-June 2025 Mood Le PArc Marcellis

LE PARC – Timeless Lines, a Bold Perspective

From the Spring/Summer 2025 collection and “Dots” campaign, Marcelis is a sophisticated combination of acetate textures and timeless lines.

Read More
Safilo Group Victoria Beckham logos July 2025

Safilo, Victoria Beckham Announce Ten-Year Global Licensing Agreement for Eyewear Collections

Safilo and Victoria Beckham announce a global ten-year eyewear licensing agreement through 2035, with a new luxury collection debuting Spring-Summer 2026.

Read More
Fighting Blindness Canada research

AIPL1 Gene Therapy Restores vision in small clinical trial

Four children with Leber congenital amaurosis 4 (LCA4) have experienced meaningful improvements in their vision after receiving a gene therapy treatment.

Read More
Essilor Varilux physop extensee logo

Essilor Announces Latest Progressive Lens Innovation: Varilux® Physio® extensee Lens

Discover Varilux Physio extensee™, Essilor’s latest innovation in progressive lenses—sharp vision, better contrast, and pupil-adaptive comfort in all light.

Learn More
CooperVision

MiSight® Spectacle Lenses Powered by Diffusion Optics Technology™ Launches in Canada to Slow Myopia Progression

Breakthrough Approach First to Use Contrast Management, Supported by Extensive Clinical Studies; Proven Highly Effective in Children as Young as Six Years Old

Read more
Optik Voila May-June 2025 Mood Le PArc Marcellis

LE PARC – Timeless Lines, a Bold Perspective

From the Spring/Summer 2025 collection and “Dots” campaign, Marcelis is a sophisticated combination of acetate textures and timeless lines.

Read more
Safilo Group Victoria Beckham logos July 2025

Safilo, Victoria Beckham Announce Ten-Year Global Licensing Agreement for Eyewear Collections

Safilo and Victoria Beckham announce a global ten-year eyewear licensing agreement through 2035, with a new luxury collection debuting Spring-Summer 2026.

Read more
Fighting Blindness Canada research

AIPL1 Gene Therapy Restores vision in small clinical trial

Four children with Leber congenital amaurosis 4 (LCA4) have experienced meaningful improvements in their vision after receiving a gene therapy treatment.

Read more
Essilor Varilux physop extensee logo

Essilor Announces Latest Progressive Lens Innovation: Varilux® Physio® extensee Lens

Discover Varilux Physio extensee™, Essilor’s latest innovation in progressive lenses—sharp vision, better contrast, and pupil-adaptive comfort in all light.

Learn More
CooperVision

MiSight® Spectacle Lenses Powered by Diffusion Optics Technology™ Launches in Canada to Slow Myopia Progression

Breakthrough Approach First to Use Contrast Management, Supported by Extensive Clinical Studies; Proven Highly Effective in Children as Young as Six Years Old

Read more
Optik Voila May-June 2025 Mood Le PArc Marcellis

LE PARC – Timeless Lines, a Bold Perspective

From the Spring/Summer 2025 collection and “Dots” campaign, Marcelis is a sophisticated combination of acetate textures and timeless lines.

Read more
Safilo Group Victoria Beckham logos July 2025

Safilo, Victoria Beckham Announce Ten-Year Global Licensing Agreement for Eyewear Collections

Safilo and Victoria Beckham announce a global ten-year eyewear licensing agreement through 2035, with a new luxury collection debuting Spring-Summer 2026.

Read more
Fighting Blindness Canada research

AIPL1 Gene Therapy Restores vision in small clinical trial

Four children with Leber congenital amaurosis 4 (LCA4) have experienced meaningful improvements in their vision after receiving a gene therapy treatment.

Read more